Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


19.02.2024

1 Am J Gastroenterol
3 BMC Cancer
2 BMC Gastroenterol
6 Clin Res Hepatol Gastroenterol
9 Dig Dis Sci
1 Gut
7 Hepatology
1 Indian J Gastroenterol
1 J Gastroenterol Hepatol
6 J Hepatol
1 N Engl J Med
2 PLoS One
1 Pol J Radiol
1 Radiol Imaging Cancer
2 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. LOUISSAINT J, Vargas HE
    Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy.
    Am J Gastroenterol. 2024 Feb 16. doi: 10.14309/ajg.0000000000002659.
    PubMed        


    BMC Cancer

  2. HITCHCOCK KE, Miller ED, Shi Q, Dixon JG, et al
    Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (
    BMC Cancer. 2024;24:201.
    PubMed         Abstract available

  3. TAO S, Cui D, Cheng H, Liu X, et al
    High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
    BMC Cancer. 2024;24:194.
    PubMed         Abstract available

  4. HU R, Xu J, Wang H, Wang J, et al
    Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysis.
    BMC Cancer. 2024;24:190.
    PubMed         Abstract available


    BMC Gastroenterol

  5. CHE Y, Tang R, Zhang H, Yang M, et al
    Development of a prediction model for predicting the prevalence of nonalcoholic fatty liver disease in Chinese nurses: the first-year follow data of a web-based ambispective cohort study.
    BMC Gastroenterol. 2024;24:72.
    PubMed         Abstract available

  6. HARI A, Stabuc B
    Possible use of 2D shear wave liver elastography in new-onset ascites evaluation.
    BMC Gastroenterol. 2024;24:68.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  7. OBADIA MA, Woimant F, Tuppin P, Debray D, et al
    Reply to "Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the National health insurance database".
    Clin Res Hepatol Gastroenterol. 2024;48:102265.
    PubMed        

  8. XIE C, Liu K, Xie Y, Liu S, et al
    Metabolism-related signalling pathways involved in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102264.
    PubMed         Abstract available

  9. GUO J, Shi L, Sun Y
    Association of composite dietary antioxidant index and muscle mass in individuals with metabolic associated fatty liver disease.
    Clin Res Hepatol Gastroenterol. 2024;48:102284.
    PubMed         Abstract available

  10. HE Q, Xiong Y, Xia P, Yang X, et al
    Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    Clin Res Hepatol Gastroenterol. 2024;48:102283.
    PubMed         Abstract available

  11. MEJAIT A, Roux C, Soret M, Larrey E, et al
    Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival.
    Clin Res Hepatol Gastroenterol. 2024;48:102282.
    PubMed         Abstract available

  12. QI X, Liu L
    The regulatory effect of lncRNA LINC00943 on the progression of hepatocellular carcinoma and its relationship with clinicopathological features.
    Clin Res Hepatol Gastroenterol. 2024;48:102273.
    PubMed         Abstract available


    Dig Dis Sci

  13. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
    Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
    PubMed         Abstract available

  14. ARE VS, Gromski MA, Akisik F, Vilar-Gomez E, et al
    Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
    Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08260.
    PubMed         Abstract available

  15. YE N, Shi X, Gao J, Dong R, et al
    Exosomes from Intrahepatic Cholestasis of Pregnancy Induce Cell Apoptosis Through the miRNA-6891-5p/YWHAE Pathway.
    Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-023-08265.
    PubMed         Abstract available

  16. SOHAL A, Kohli I, Chaudhry H, Singh I, et al
    Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08202.
    PubMed         Abstract available

  17. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
    Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:370-383.
    PubMed         Abstract available

  18. FIGUEROA G, Castaneda S, McLean H, Dukandar J, et al
    Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:384-398.
    PubMed         Abstract available

  19. WAJSBROT NB, Leite NC, Franca PHC, Cardoso CRL, et al
    Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2024;69:634-642.
    PubMed         Abstract available

  20. ASHKTORAB H, Challa SR, Singh G, Nanduri S, et al
    Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
    Dig Dis Sci. 2024;69:562-569.
    PubMed         Abstract available

  21. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
    Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
    Dig Dis Sci. 2024;69:643-644.
    PubMed        


    Gut

  22. KEATING CR, Calvisi DF, Qiu W
    High-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation.
    Gut. 2024 Feb 9:gutjnl-2023-331857. doi: 10.1136/gutjnl-2023-331857.
    PubMed        


    Hepatology


  23. Hepatology Highlights.
    Hepatology. 2024;79:255-256.
    PubMed        

  24. EHRENBAUER AF, Egge JFM, Gabriel MM, Tiede A, et al
    Comparison of six tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome - A prospective, observational study.
    Hepatology. 2024 Feb 13. doi: 10.1097/HEP.0000000000000770.
    PubMed         Abstract available

  25. MOCTEZUMA-VELAZQUEZ C, Wong YJ, Montano-Loza AJ
    Editorial: Promise and pitfalls of a natural killer cell signature for hepatocellular carcinoma detection in HCV patients with sustained virological response.
    Hepatology. 2024 Feb 14. doi: 10.1097/HEP.0000000000000797.
    PubMed        


  26. Erratum: An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations.
    Hepatology. 2024;79:E105.
    PubMed        

  27. ZHU M, Liu Z, Chen S, Luo Z, et al
    Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study.
    Hepatology. 2024 Feb 15. doi: 10.1097/HEP.0000000000000776.
    PubMed         Abstract available

  28. AGRAWAL D, Ariga KK
    Liver, heart, and kidney crosstalk in cirrhosis: POCUS is the focus.
    Hepatology. 2024 Feb 14. doi: 10.1097/HEP.0000000000000789.
    PubMed        

  29. ALLEGRETTI AS, Patidar KR, Ma AT, Cullaro G, et al
    From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.
    Hepatology. 2024 Feb 14. doi: 10.1097/HEP.0000000000000790.
    PubMed         Abstract available


    Indian J Gastroenterol

  30. PATIDAR Y, Mittal K, Patel RK, Thomas SS, et al
    Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child-Pugh, model for end-stage liver diseases and indocyanine green dye test.
    Indian J Gastroenterol. 2024 Feb 13. doi: 10.1007/s12664-023-01490.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  31. JI PX, Chen YX, Ni XX, Miao Q, et al
    Effect of triggering receptor expressed on myeloid cells 2-associated alterations on lipid metabolism in macrophages in the development of non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2024;39:369-380.
    PubMed         Abstract available


    J Hepatol

  32. DE VILLE DE GOYET J
    Tailoring allocation policies and improving access to pediatric liver transplantation in Italy: outframing and concluding: Comment on:Tailoring allocation policies and improving access to pediatric liver transplantation over a 16-year period. Spada M,
    J Hepatol. 2024 Feb 12:S0168-8278(24)00126-0. doi: 10.1016/j.jhep.2024.
    PubMed        

  33. YANG H, Jang JW
    Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!'.
    J Hepatol. 2024 Feb 10:S0168-8278(24)00123-5. doi: 10.1016/j.jhep.2024.
    PubMed        

  34. ARTRU F, Reiberger T
    One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis.
    J Hepatol. 2024 Feb 8:S0168-8278(24)00118-1. doi: 10.1016/j.jhep.2024.
    PubMed        

  35. ALLWEISS L, Volmari A, Suri V, Wallin JJ, et al
    Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies.
    J Hepatol. 2024 Feb 8:S0168-8278(24)00114-4. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  36. SOIN A, Lesurtel M, Clavien PA
    To the editor: Reply to the letter by Liu et al. entitled "Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation: A meta-analysis".
    J Hepatol. 2024 Feb 8:S0168-8278(24)00101-6. doi: 10.1016/j.jhep.2024.
    PubMed        

  37. HUANG CH, Tsai MH, Lin CY
    Identifying the pivotal role of non-acute decompensation as a precursor to acute decompensation in cirrhosis.
    J Hepatol. 2024 Feb 7:S0168-8278(24)00119-3. doi: 10.1016/j.jhep.2024.
    PubMed        


    N Engl J Med

  38. HARRISON SA, Bedossa P, Guy CD, Schattenberg JM, et al
    A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
    N Engl J Med. 2024;390:497-509.
    PubMed         Abstract available


    PLoS One

  39. LIU Z, Shao Y, Duan X
    Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298225.
    PubMed         Abstract available

  40. MATSUO M, Kanbe A, Noguchi K, Niwa A, et al
    Time-course analysis of liver and serum galectin-3 in acute liver injury after alpha-galactosylceramide injection.
    PLoS One. 2024;19:e0298284.
    PubMed         Abstract available


    Pol J Radiol

  41. SALAHSHOUR F, Khameneh AG, Amirkhiz GDH, Yazdi NA, et al
    Texture analysis on routine MRI sequences to differentiate between focal nodular hyperplasia and hepatocellular adenoma.
    Pol J Radiol. 2023;88:e589-e596.
    PubMed         Abstract available


    Radiol Imaging Cancer

  42. ALBUQUERQUE J, Lin YM, Paolucci I, O'Connor CS, et al
    Incidental Ring-hyperenhancing Liver Micronodules at CT Hepatic Arteriography-guided Percutaneous Thermal Ablation of Colorectal Liver Metastases.
    Radiol Imaging Cancer. 2024;6:e230099.
    PubMed         Abstract available


    Radiology

  43. GEMMETE JJ
    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.
    PubMed        

  44. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.